The Power of $4 bill Drug Ads: Doctors Respond with Diagnosis & Prescription – WashPost Thu, 28 Apr 2005 What does $4 billion dollars in drug advertising buy? The Washington Post reports that a University of Washington study published in the Journal of the American Medical Association confirms the insidious…
Depressing news for GSK Thu, 14 Apr 2005 A class lawsuit by US investors has been filed against GlaxoSmithKline in the US federal District Court in New York, alleging violation of securities laws. The suit charges GSK issued “false or misleading public statements” about the antidepressant, Paxil (Seroxat). The law…
US Marshals Seize Millions of Defective Paxil & Avandamet pills_NYT Mon, 7 Mar 2005 The FDA and federal marshals yanked millions of tablets of the antidepressant, Paxil CR (Seroxat, controlled release) and the diabetes drug, Avandamet, off the market because they are defective. The Paxil pills split during manufacturing, and…
Doctors, Too, Ask: Is This Drug Right? Thu, 30 Dec 2004 Much to their professional embarassment, doctors are finding that they have been fed a pack of lies by smooth talking pharmaceutical company sales reps, who persuaded them that the new, and (always) more expensive drugs provided a greater benefit…
Bradshaw cancels appearance after SSRI-Citizen Press Release Announced Protest Fri, 13 Aug 2004 FDA’s failure to enforce the law that requires drug companies to tell the truth in their drug advertisements and promotions about the safety and effectiveness of their drugs, has prompted citizen groups to take the initiative and…
FDA Chief Counsel, Daniel Troy, Resigned Wed, 17 Nov 2004 FDA’s chief counsel, Daniel Troy, has resigned! This is good news for consumers. Troy was the symbol of what is rotten at the FDA: the pharmaceutical industry’s influence has ensured that business interests take precedence over public safety. Industry-influenced advisory…
FDA Protects Pfizer: Removes Advisory Panelist for Citing Evidence Bextra Similar to Vioxx – WSJ Fri, 12 Nov 2004 Even as the Vioxx casualties are still being counted, even as FDA’s conduct is under Congressional investigation, the FDA office of new drugs has taken action to obstruct evidence-based safety evaluation…
SEC Focusing on Drug Makers Disclosure_ Continuing Medical Ed Changes Tue, 28 Sep 2004 Evidence showing that drug manufacturers and the FDA concealed negative clinical trial data and deceived physicians, consumers, and shareholders about failure to demonstrate the safety and effectiveness of SSRI antidepressant drugs has caught the interest of…
18% decrease SSRI use in Youth – NYT / Suicide Risk Not New – Globe / Prozac no different Tue, 21 Sep 2004 The FDA failed to stop drug manufacturers from flooding the air waves and the scientific literature with false and scientifically invalid claims-based on partial data. “The FDA…
FDA’s Waiting Game Exposes Children to Preventable Risks Comments by Vera Hassner Sharav President The Alliance for Human Research Protection Submitted to FDA Advisory Committee Psychopharmacological Drugs Advisory Committee and Pediatric Subcommittee Drugs Advisory Committee September 13-14, 2004 Meeting RE: Suicidality Associated with Antidepressant Drug Treatment The Alliance for Human…
ALLIANCE FOR HUMAN RESEARCH PROTECTION (AHRP) 142 West End Ave. Suite 28P, New York, NY 10023 ***PRESS RELEASE*** September 11, 2004 Contact: Vera Hassner Sharav, President, AHRP Tel. No: 212-595-8974 Cell: 917-375-5083 ***AHRP PRESS BRIEFING*** Re: Antidepressants and suicide-related risks for children When: September 14, 2004, 12:00 P.M. Where: Holiday…
Clinical Trials Controversy Spotlights Flawed System – Psychiatric News Mon, 19 Jul 2004 Recent independent analyses of the published and unpublished SSRI antidepressant pediatric data submitted by manufacturers to the FDA reveal not only that a disparity exists between published and unpublished data, but it becomes increasingly clear that the…
